MedTrace Logo

Vascular Effects of a Single Bout of Electronic Cigarette Use

NCT03209661 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2018-10-11

No results posted yet for this study

Summary

Investigating the acute effects of a single use E-Cigarette upon vascular health.

Conditions

  • Arterial Stiffness

Interventions

DRUG

E-cigarette

E-Cigarette containing 5.4% nicotine will be administered to determine the effects on vascular function.

DRUG

Nicotine 0%

E-Cigarette containing 0% nicotine will be administered to determine the effects on vascular function.

DRUG

Menthol Inhalant Product

Menthol inhaler will be administered to determine the effects on vascular function.

Sponsors & Collaborators

  • University of Texas at Austin

    lead OTHER

Principal Investigators

  • Hirofumi Tanaka, Phd · University of Texas

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-04-28
Primary Completion
2018-08-01
Completion
2018-08-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03209661 on ClinicalTrials.gov